Lumbar Spondylosis Clinical Trial
Official title:
A Phase I Study Evaluating the Safety and Feasibility of Platelet-rich Plasma for the Treatment of Facetogenic Low Back Pain
Verified date | June 2023 |
Source | Mayo Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is being done to assess the safety of using the Angel Concentrated Platelet Rich Plasma System to process Platelet Rich Plasma (PRP) to treat arthritis of the low back (lumbar spondylosis).
Status | Active, not recruiting |
Enrollment | 4 |
Est. completion date | July 2024 |
Est. primary completion date | July 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 22 Years to 70 Years |
Eligibility | Inclusion Criteria: - Clinical and radiographic (MRI, CT or lumbar x-ray) evidence of symptomatic facet arthropathy involving the bilateral bottom two facets (e.g., L4-5 or L5-6 and L5-S1 or L6-S1). - Positive response, defined according to current clinical standards for the diagnosis of facet-mediated low back pain as greater than or equal to 75% pain improvement (as reported by patient) to diagnostic medial branch nerve blocks, one block with lidocaine and the other with bupivacaine. - Low back pain VAS score of greater than or equal to 5 at the clinical visit just prior to the first medial branch nerve block. Exclusion Criteria: - Prior facet related procedure (intraarticular corticosteroid injection, radiofrequency ablation (RFA)) in last 6 months or prior fusion in the bottom two facets. - Current opioid use of greater than 50mg oral morphine milligram equivalents per day. - No advanced imaging (MRI, CT or lumbar x-ray) of the lumbar spine within the last 6 months. - BMI > 34.99 (WHO class I obesity). - Active systemic or local infection as evidenced by fever >100.4 degrees Fahrenheit, or any other clinical signs or symptoms of infection within 24 hours of the procedure. - On anticoagulation drug and has been on hold for less than 7 days prior to the investigational procedure. - Imaging evidence of high likelihood of failure for intra-articular injection in the opinion of the PI or delegate review of MRI, CT or lumbar x-ray imaging. - History of chronic thrombocytopenia (or pre-operative platelet count less than 195,000 per µl). - Undergoing chemotherapy at time of injection. - Pregnant or breastfeeding. - Use of illicit drugs within 30 days prior to study entry. - NSAID use during the pre-procedural period (one week before Treatment Day 0). - Preoperative hematocrit less than 36%. - History of hemodynamic instability or inability to maintain stable oncotic pressure. - History of prolonged clotting times. - Prior history of lumbar procedure. - Redness, swelling, rash or other concerning lesions at the injection site just prior to the procedure. - Prior history of allergy to lidocaine or other local anesthetic agent. |
Country | Name | City | State |
---|---|---|---|
United States | Mayo Clinic in Rochester | Rochester | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Matthew Pingree |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of adverse device effects | Adverse device effects related to the processing of the platelet rich plasma product (such as hardware failures/malfunctions, software errors, disposable set equipment malfunctions, processing errors, automatic self-test/calibration errors, variations in hematocrit level in final product, variations in total volume of PRP concentrate produced, etc.) | Day 0 (Day of procedure) | |
Primary | Number of suspected acute adverse reactions to the treatment | Suspected adverse reactions to the treatment based on evaluations including follow-up physical examinations, labs and assessment of clinical signs and symptoms. | Day 0 to Day 14 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04140344 -
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
|
N/A | |
Completed |
NCT00788008 -
Cognitive Effects of Inhalational Versus Intravenous General Anesthesia in the Elderly
|
N/A | |
Completed |
NCT04091607 -
Using Music During Lumbar Medial Branch Block Procedure
|
N/A | |
Recruiting |
NCT05405374 -
OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study
|
N/A | |
Completed |
NCT03532230 -
Cost Effectiveness of OMT for Chronic Low Back Pain
|
||
Active, not recruiting |
NCT05993195 -
Re-operation Rates of Concorde Bullet Device Versus Conduit Titanium Interbody Graft for Lumbar Fusion
|
||
Terminated |
NCT02276911 -
Safety and Efficacy of Pre-incisional Intravenous Ibuprofen to Reduce Postoperative Pain and Opioid Dependence After Posterior Cervical or Lumbar Instrumented Spine Surgery
|
Phase 2 | |
Completed |
NCT04970732 -
Effect of Chewing Gum on Abdominal Distension in Patients After Lumbar Spine Surgery
|
N/A | |
Not yet recruiting |
NCT06283628 -
Comparative Effectiveness of Two Different Approaches to Radiofrequency Ablation of Lumbar Medial Branch Nerves
|
N/A | |
Completed |
NCT05345249 -
Erector Spinae Plane Block as Pain Management After Lumbar Fusion Surgery
|
Phase 4 | |
Recruiting |
NCT03439228 -
To Brace or Not to Brace for Single Level Lumbar Fusion Pilot
|
N/A | |
Recruiting |
NCT05029726 -
Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery
|
Phase 4 | |
Completed |
NCT03484403 -
Benefit of Lumbar Bracing for Chronic Low Back Pain Due to Degenerative Disc Disease
|
N/A | |
Recruiting |
NCT05505981 -
An Immediate Functional Progression Program for Adolescent Athletes With Spondylolysis
|
N/A | |
Completed |
NCT03647501 -
Lumbar Fusion With Nexxt Spine 3D-Printed Titanium Interbody Cages
|
N/A | |
Completed |
NCT01292252 -
Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion
|
Phase 4 | |
Completed |
NCT04747483 -
EOTA With Or Without Mechanical Traction For Patients With Lumbar Spondylosis
|
N/A | |
Recruiting |
NCT05854043 -
Modified Enhanced Recovery After Oblique Lateral Interbody Fusion Surgery
|
N/A |